Preferred Label : depressive disorder, major;

MeSH definition : Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.; Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Other symptoms include 1. Depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt.; Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5); Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every day; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5);

MeSH synonym : major depressive disorder; depressive disorders, major; major depressive disorders; Clinical Depression;

CISMeF synonym : disorder, major depressive; disorders, major depressive;

MeSH hyponym : paraphrenia, involutional; Involutional Paraphrenia; Involutional Paraphrenias; Paraphrenias, Involutional;

Related MeSH term : psychosis, involutional; depression, involutional; Involutional Psychoses; Involutional Psychosis; Psychoses, Involutional; Involutional Depression; Melancholia, Involutional; Involutional Melancholia;

Wikipedia link : https://en.wikipedia.org/wiki/Major depressive disorder;

Details


Main resources

You can consult :

Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.
Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Other symptoms include 1. Depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt.
Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)
Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every day; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/ajustement-des-antidepresseurs-pour-le-suivi-dun-trouble-depressif-caracterise-majeur-ou-dun-trouble-anxieux.html
2024
false
false
false
Canada
depressive disorder, major
anxiety disorders
antidepressive agents
panic disorder
adult
antidepressive agents
Healthy Lifestyle
technical report
guideline

---
https://www.ameli.fr/medecin/exercice-liberal/memos/bon-usage-antidepresseurs-patients-ages
2024
France
scientific and technical information
depressive disorder, major
depression
patient care management
age more than 65 years
aged
due to
episode of
depressive disorder
depression, nos
shock

---
https://www.cochrane.org/fr/CD004692/DEPRESSN_utilisation-des-acides-gras-omega-3-dans-la-depression-chez-ladulte
2021
false
false
false
false
France
United Kingdom
French
review of literature
depressive disorder, major
fatty acids, Omega-3
fatty acids, Omega-3
treatment outcome
french abstract
adult

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-41-no-11-2021/symptomes-trouble-depressif-majeur-pandemie-covid-19-echantillon-representatif-population-canadienne.html
2021
Canada
COVID-19
journal article
depression
depressive disorder
resulting in
pandemics
symptom, nos
depressive symptoms
population
depressive disorder, nos
Symptom
depressive disorder, major

---
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=33077528
2020
false
false
false
Canada
coronavirus infections
pneumonia, viral
journal article
Human
Human
Human
Human
Human
Human
Human
depressive disorder, major
tomography, X-ray computed
homo sapiens
Human
Accidental blood exposure
Human
humans
pandemics
COVID-19

---
https://www.inesss.qc.ca/covid-19/investigation-procedures-diagnostiques/tdm-thoracique.html
2020
Canada
guideline
tomography, X-ray computed
depressive disorder, major
pneumonia, viral
coronavirus infections
COVID-19

---
BENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69506a-fra.php
2019
false
false
false
Canada
French
English
depressive disorder, major
belimumab
belimumab
self-injurious behavior
lupus erythematosus, systemic
pharmacovigilance note
patients guideline
risk assessment
antibodies, monoclonal, humanized

---
https://www.cfp.ca/content/65/8/e336
2019
false
true
false
false
Canada
child
depression
fluoxetine
depressive disorder, major
adolescent
depressive disorder, major
Selective Serotonin Reuptake Inhibitors
fluoxetine
fluoxetine
journal article

---
https://www.cochrane.org/fr/CD001026/antidepresseurs-et-benzodiazepines-pour-traiter-la-depression-majeure
2019
false
false
false
France
United Kingdom
treatment outcome
drug therapy, combination
review of literature
french abstract
antidepressive agents
benzodiazepines
depressive disorder, major

---
https://papyrus.bib.umontreal.ca/xmlui/handle/1866/22096
2019
Canada
dissertations, academic
female
depressive disorder, major
depressive disorder, nos
women
depression
qualitative research
quebec
stereotyping
depressive disorder
female
women
depression

---
http://www.sudoc.fr/235154369
2019
France
dissertations, academic
depressive disorder
France
France
prevalence
depressive disorder, nos
sexuality
France
antidepressive agents
sexual state, nos
patient care management
France
depression
episode of
french
antidepressant, nos
depressive disorder, major
therapeutics
men
france
sexual dysfunction, nos
depression

---
https://dumas.ccsd.cnrs.fr/dumas-01723561
2018
false
false
false
France
French
dissertations, academic
arrested
adulthood
depression, nos
Acrosíndrome
episode of
Physicians
Adult
general practitioners
antidepressant, nos
due to
antidepressive agents
generalized
depression
depressive disorder
propping zerres syndrome
febrile convulsion
Adult
adult
Epidermolytic acanthoma
depressive disorder, major
depression
anodontia
breast
ectodermal dysplasia
lacrimal duct obstruction
nails, malformed
pigmentation disorders
limb deformities, congenital

---
http://www.ssmg.be/wp-content/uploads/RMG/351/RMG351_06-11.pdf
2018
false
false
true
Belgium
aged
depressive disorder, major
general practice
depressive disorder, major
practice guideline
depressive disorder, major
signs and symptoms
journal article
adult

---
https://dumas.ccsd.cnrs.fr/dumas-02766854
2018
France
dissertations, academic
Cholesteatoma
fusion, nos
Grassland
cholesteatoma, middle ear
depressive disorder, major
protective devices
cholesteatoma of middle ear
diffusion magnetic resonance imaging
recurrence
tomography, X-ray computed
magnetic resonance imaging, nos

---
https://dumas.ccsd.cnrs.fr/dumas-01647688
2017
false
false
false
France
French
dissertations, academic
inpatients
hospitals
hospitalization
patients
antidepressive agents
treaties
depression
recommendations, health planning
inpatients
hospitals
hospitalization
patients
antidepressive agents
therapeutics
depressive disorder, major
depression
depressive disorder
directive counseling
guideline adherence
international cooperation
health planning guidelines

---
https://www.has-sante.fr/portail/jcms/c_1739917/fr/episode-depressif-caracterise-de-l-adulte-prise-en-charge-en-premier-recours
2017
false
false
true
France
French
practice guideline
depressive disorder, major
adult
aged
signs and symptoms
depressive disorder, major
severity of illness index
risk assessment
suicidal ideation
depressive disorder, major
depressive disorder, major
psychotherapy
pregnancy
breast feeding
antidepressive agents
Cognitive Behavioral Therapy
watchful waiting
psychiatric status rating scales
hospitalization
behavior, addictive
continuity of patient care
Selective Serotonin Reuptake Inhibitors
Serotonin and Noradrenaline Reuptake Inhibitors
antidepressants
antidepressive agents, tricyclic
antidepressive agents, second-generation
monoamine oxidase inhibitors
drug interactions
antidepressive agents
treatment outcome
comparative effectiveness research
Tricyclic antidepressant drug adverse reaction (disorder)
Tetracyclic antidepressant drug adverse reaction (disorder)
Monoamine oxidase inhibitor adverse reaction (disorder)
Selective serotonin re-uptake inhibitor adverse reaction (disorder)
mianserin
tianeptine
agomelatine
diagnosis, differential
agomelatine
thiazepines
piperazines
sulfides
acetamides
Vortioxetine
Mirtazapine

---
https://dumas.ccsd.cnrs.fr/dumas-01421776
2016
false
false
false
France
French
dissertations, academic
general practitioners
depressive disorder, major
general practice
screening
generalized
depression, nos
depressive disorder
france
qualitative
french
depression
questionnaires
diagnosis
episode of
mass screening
depression
Surveys and Questionnaires

---
http://www.lecrat.eu/?s=Dulox%C3%A9tine+dans+la+d%C3%A9pression+-+Grossesse+et+allaitement
2016
false
false
false
false
France
French
drug information
duloxetine
antidepressive agents
Selective Serotonin Reuptake Inhibitors
Duloxetine Hydrochloride
breast feeding
depressive disorder, major
pregnancy

---
https://minerva-ebp.be/FR/Article/2051
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
depressive disorder, major
aged
depressive disorder, Treatment-Resistant
Aripiprazole
Aripiprazole
treatment outcome
antipsychotic agents
antipsychotic agents
basal ganglia diseases
randomized controlled trials as topic
middle aged

---
https://medicalforum.ch/fr/detail/doi/fms.2016.02704/
false
false
false
depression, nos
episode of
therapeutics
depressive disorder
high pitch
acute
depressive disorder, major
treaties
depression
acute disease

---
http://labodessavoirs.fr/emissions-du-labo/la-psychiatrie-et-ses-medicaments/
2016
false
false
false
France
French
antipsychotic agents
radio broadcast
treatment outcome
schizophrenia
depressive disorder, major
anti-anxiety agents
antidepressive agents
psychotropic drugs
bipolar disorder
antimanic agents
benzodiazepines

---
Geriatric Depression Scale (GDS)
https://cnfs.ca/agees/tests/mesurer-l-affect/echelle-de-depression-geriatrique-gds
https://web.stanford.edu/~yesavage/FrenchCan.html
2015
false
true
false
Canada
French
geriatric assessment
aged
depressive disorder
clinical tool
mass screening
Geriatric depression scale (assessment scale)
depressive disorder, major

---
http://www.cochrane.org/fr/CD004044/traitement-pharmacologique-contre-la-depression-psychotique
http://www.cochrane.org/fr/CD004044
2015
false
France
United Kingdom
French
meta-analysis
review of literature
antipsychotic agents
depressive disorder, major
treatment outcome
antidepressive agents
drug therapy, combination
DEPRESSION PSYCHOTIC

---
http://kce.fgov.be/fr/publication/report/d%C3%A9pression-majeure-de-l%E2%80%99adulte-efficacit%C3%A9-%C3%A0-long-terme-de-la-psychoth%C3%A9rapie-seule#.VC1BSRZBprI
2014
false
true
false
Belgium
French
french abstract
practice guideline
depressive disorder, major
depressive disorder, major
antidepressive agents
psychotherapy
comparative study
treatment outcome
antidepressive agents
combined modality therapy

---
http://www.has-sante.fr/portail/jcms/c_1742730/fr/mise-en-oeuvre-de-leducation-therapeutique-dans-le-cadre-de-lexperimentation-paerpa
http://www.has-sante.fr/portail/jcms/c_1764017/fr/cadre-referentiel-etp-paerpa-depression
http://www.has-sante.fr/portail/jcms/c_1764016/fr/cadre-referentiel-etp-paerpa-prevention-des-chutes
http://www.has-sante.fr/portail/jcms/c_1764007/fr/cadre-referentiel-etp-paerpa-polypathologie/polymedication
2014
false
true
false
France
French
patient education as topic
depressive disorder, major
accidental falls
polypharmacy
scientific and technical information
aged

---
http://savoirs.usherbrooke.ca/handle/11143/5969
2014
false
true
false
Canada
French
dissertations, academic
exercise
depressive disorder, major
adult
depression

---
http://www.revmed.ch/RMS/2014/RMS-N-448/Traitement-de-la-depression-resistante.-Securite-et-efficacite-de-la-stimulation-magnetique-transcranienne
2014
false
false
false
Switzerland
French
journal article
depressive disorder, Treatment-Resistant
depressive disorder, major
transcranial magnetic stimulation
antidepressive agents
treatment outcome

---
https://papyrus.bib.umontreal.ca/xmlui/handle/1866/11219
2014
false
true
false
Canada
French
dissertations, academic
chronic pain
depressive disorder, major

---
http://www.has-sante.fr/portail/jcms/c_1782013/fr/manifestations-depressives-a-l-adolescence-reperage-diagnostic-et-prise-en-charge-en-soins-de-premier-recours
http://www.has-sante.fr/portail/jcms/c_1794384/fr/manifestations-depressives-argumentaire-scientifique
2014
false
true
false
France
French
depressive disorder, major
adolescent
practice guideline
depressive disorder, major
early diagnosis
depressive disorder, major
signs and symptoms
depressive disorder, major
diagnosis, differential
risk factors
suicidal ideation
suicide
depressive disorder, major
mass screening
disease management
psychotherapy
depressive disorder, major
treatment outcome
Cognitive Behavioral Therapy
antidepressive agents
antidepressive agents
combined modality therapy
anxiety disorders
comorbidity
questionnaires
psychiatric status rating scales

---
https://www.revmed.ch/RMS/2014/RMS-N-448/Traitement-de-la-depression-resistante.-Securite-et-efficacite-de-la-stimulation-magnetique-transcranienne
2014
false
false
false
Switzerland
French
journal article
depressive disorder, major
depressive disorder, Treatment-Resistant
transcranial magnetic stimulation
treatment outcome

---
http://www.cochrane.org/fr/CD008851/lagomelatine-par-rapport-a-dautres-medicaments-antidepresseurs-pour-le-traitement-de-la-depression
2013
false
false
false
France
United Kingdom
meta-analysis
french abstract
depressive disorder, major
treatment outcome
agomelatine
antidepressive agents
agomelatine
antidepressive agents
comparative study
Selective Serotonin Reuptake Inhibitors
adult

---
http://www.cochrane.org/fr/CD008696
2013
United Kingdom
France
French
review of literature
depressive disorder, major
psychotherapy
behavior therapy
treatment outcome
french abstract
adult

---
https://rmlg.uliege.be/article/2458
2013
false
false
false
Belgium
French
journal article
depressive disorder, major
antipsychotic agents
treatment outcome
bipolar disorder
depression, bipolar
unipolar depression
depressive disorder
depressive disorder, Treatment-Resistant
Atypical antipsychotic (substance)
Atypical antipsychotic (product)
aripiprazole
antidepressive agents
drug therapy, combination
antipsychotic agents
clinical trials as topic
quetiapine
olanzapine
olanzapine-fluoxetine combination
risperidone
review of literature
risperidone
Delayed-Action preparations
secondary prevention
Quetiapine Fumarate
Aripiprazole
benzodiazepines
fluoxetine
Olanzapine

---
https://www.revmed.ch/RMS/2012/RMS-365/Depression-analyse-decisionnelle-pour-la-prise-en-charge-par-le-medecin-de-premier-recours
2012
Switzerland
French
depressive disorder, major
journal article
depressive disorder, major
diagnosis, differential
psychiatric status rating scales
algorithms
depressive disorder, major
antidepressive agents
depressive disorder, major
psychotherapy
antidepressive agents
suicide

---
http://www.cochrane.org/fr/CD008121
2012
United Kingdom
France
French
meta-analysis
depressive disorder, major
antipsychotic agents
treatment outcome
dysthymic disorder
french abstract

---
https://rmlg.uliege.be/article/2377
2012
false
Belgium
French
Duloxetine Hydrochloride
Aripiprazole
depressive disorder, major
journal article
case reports
antidepressive agents
antipsychotic agents
drug therapy, combination
depressive disorder, Treatment-Resistant
chronic disease

---
http://www.cochrane.org/fr/CD009138
2012
United Kingdom
France
French
meta-analysis
depressive disorder, major
amitriptyline
treatment outcome
adult
antidepressive agents, tricyclic
amitriptyline
antidepressive agents, tricyclic
french abstract

---
http://www.cochrane.org/fr/CD006534
2012
United Kingdom
France
French
meta-analysis
depressive disorder, major
antidepressive agents
citalopram
treatment outcome
french abstract

---
https://www.inspq.qc.ca/sites/default/files/publications/1509_fairefacedepressionqc_protosoinsinterv1religne.pdf
2012
Canada
French
depressive disorder, major
practice guideline
depressive disorder, major
severity of illness index
depressive disorder, major
antidepressive agents
depressive disorder, major
questionnaires
algorithms

---
https://minerva-ebp.be/fr/article/274
false
false
minerva-ebm.be
Belgium
French
Dutch
drug therapy, combination
treatment outcome
antipsychotic agents
antidepressive agents
adult
meta-analysis as topic
antidepressive agents
depressive disorder, major
antipsychotic agents
depressive disorder, Treatment-Resistant
critical appraisal or critical reading

---
http://www.cochrane.org/fr/CD006528
2011
false
United Kingdom
France
French
meta-analysis
depressive disorder, major
treatment outcome
antidepressive agents, tricyclic
adult
french abstract
Mirtazapine

---
http://www.cochrane.org/fr/CD006114
2010
United Kingdom
France
French
meta-analysis
depression
depressive disorder, major
antidepressive agents
fluvoxamine
treatment outcome
Selective Serotonin Reuptake Inhibitors
antidepressive agents, second-generation
french abstract

---
http://www.cochrane.org/fr/CD006117
2010
United Kingdom
France
French
meta-analysis
depressive disorder, major
treatment outcome
sertraline
antidepressive agents
comparative study
Selective Serotonin Reuptake Inhibitors
depression
french abstract

---
https://minerva-ebp.be/fr/article/359
2009
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
antidepressive agents
depressive disorder, major

---
http://www.erudit.org/revue/smq/2009/v34/n1/029760ar.html?vue=resume
2009
Canada
journal article
review literature
depressive disorder
depressive disorder, major
review literature as topic

---
http://www.stacommunications.com/journals/leclinicien/2009/08-Sept-09/WNiCR%20Sept%202009%20Cipralex%20French.pdf
2009
Canada
French
depressive disorder, major
antidepressive agents, second-generation
journal article

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Pristiq_September-25-2009_f.pdf
2009
false
Canada
French
Desvenlafaxine Succinate
treatment outcome
depressive disorder, major
antidepressive agents
drug evaluation

---
https://www.revmed.ch/RMS/2009/RMS-196/Le-millepertuis-dans-le-traitement-de-la-depression-majeure
2009
false
false
Switzerland
French
depressive disorder, major
treatment outcome
hypericum
hypericum
Contraindications, Procedure
Hyperici herba
critical appraisal or critical reading
meta-analysis

---
https://minerva-ebp.be/fr/article/358
2009
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
comparative study
sertraline
depressive disorder, major
antidepressive agents

---
https://minerva-ebp.be/fr/article/557
2008
false
false
minerva-ebm.be
Belgium
French
Selective Serotonin Reuptake Inhibitors
antidepressive agents, second-generation
depressive disorder, major
child
adolescent
obsessive-compulsive disorder
Selective Serotonin Reuptake Inhibitors
suicide
risk factors
anxiety disorders
critical appraisal or critical reading

---
https://www.revmed.ch/RMS/2008/RMS-171/La-depression-majeure-avec-symptomes-psychotiques
2008
Switzerland
journal article
depressive disorder, major
depressive symptoms
depressive disorder

---
http://www.phac-aspc.gc.ca/publicat/cdic-mcc/28-3/pdf/cdic28-3-1fra.pdf
2008
Canada
occupational exposure
journal article
bipolar disorder
bipolar disorder
employment
bipolar disorder, nos
depressive disorder
depressive disorder, major

---
https://minerva-ebp.be/fr/article/652
2007
false
false
minerva-ebm.be
Belgium
French
comparative study
depressive disorder, major
citalopram
treatment outcome
antidepressive agents, second-generation
Selective Serotonin Reuptake Inhibitors
depressive disorder, Treatment-Resistant
critical appraisal or critical reading

---
https://minerva-ebp.be/fr/article/653
2007
false
false
minerva-ebm.be
Belgium
French
secondary prevention
recurrence
depressive disorder, major
aged
paroxetine
Selective Serotonin Reuptake Inhibitors
antidepressive agents, second-generation
psychotherapy
depressive disorder, major
critical appraisal or critical reading

---
http://www.has-sante.fr/portail/display.jsp?id=c_607702
http://www.has-sante.fr/portail/display.jsp?id=c_607707
http://www.has-sante.fr/portail/display.jsp?id=c_607708
http://www.has-sante.fr/portail/display.jsp?id=c_608188
2007
true
France
French
risk factors
psychiatry
depressive disorder, major
signs and symptoms
aged
depressive disorder, major
phototherapy
psychotherapy
antidepressive agents
depressive disorder, major
continuity of patient care
suicide
depressive disorder, major
adult
depressive disorder, major
chronic disease
depressive disorder, major
recurrence
practice guideline
french abstract
retraction of publication

---
http://www.dspq.qc.ca/publications/Dépression_majeure_en_première_ligne_-_revue_de_la_littérature.pdf
2006
scientific and technical information
review literature as topic
depressive disorder
review literature
depressive disorder, major

---
https://drees.solidarites-sante.gouv.fr/sites/default/files/2020-10/er545.pdf
2006
false
true
false
France
population surveillance
journal article
population characteristics
depressive disorder, major
risk factors

---
http://revmed.ch/RMS/2006/RMS-52/31042
2006
journal article
clinical practice guideline
guidelines as topic
depressive disorder, major
depressive disorder
rehabilitation
hospitals, general

---
http://www.reseau-pic.info/?dest=medicaments/venlafaxine.htm&med=EFFEXOR®
2006
false
France
French
Venlafaxine Hydrochloride
Venlafaxine Hydrochloride
Selective Serotonin Reuptake Inhibitors
Selective Serotonin Reuptake Inhibitors
antidepressive agents, second-generation
antidepressive agents, second-generation
depressive disorder, major
phobic disorders
patient education handout

---
https://www.cadth.ca/sites/default/files/pdf/108_No72_selegiline_edrug_f.pdf
2006
Canada
French
administration, cutaneous
selegiline
depressive disorder, major
depression
clinical trials as topic
selegiline
transdermal patch
drug evaluation

---
http://www.reseau-pic.info/?dest=medicaments/citalopram.htm&med=CITALOPRAM®
2006
France
French
citalopram
citalopram
antidepressive agents, second-generation
antidepressive agents, second-generation
Selective Serotonin Reuptake Inhibitors
Selective Serotonin Reuptake Inhibitors
depressive disorder, major
panic disorder
patient education handout

---
http://www.dspq.qc.ca/publications/D%C3%A9pression_majeure_en_premi%C3%A8re_ligne_-_revue_de_la_litt%C3%A9rature.pdf
2006
Canada
technical report
review literature as topic
review literature
depressive disorder, major
depressive disorder

---
http://www.reseau-pic.info/?dest=medicaments/fluoxetine.htm&med=FLUOXETINE®
2006
France
French
fluoxetine
fluoxetine
antidepressive agents, second-generation
antidepressive agents, second-generation
Selective Serotonin Reuptake Inhibitors
Selective Serotonin Reuptake Inhibitors
depressive disorder, major
obsessive-compulsive disorder
bulimia
patient education handout

---
http://www.reseau-pic.info/?dest=medicaments/milnacipran.htm&med=IXEL®
2006
France
French
cyclopropanes
cyclopropanes
antidepressive agents
antidepressive agents
Selective Serotonin Reuptake Inhibitors
Selective Serotonin Reuptake Inhibitors
adrenergic uptake inhibitors
adrenergic uptake inhibitors
depressive disorder, major
cyclopropanes
patient education handout
Milnacipran

---
http://www.reseau-pic.info/?dest=medicaments/paroxetine.htm&med=PAROXETINE®
2006
France
French
paroxetine
depressive disorder, major
antidepressive agents, second-generation
Selective Serotonin Reuptake Inhibitors
paroxetine
antidepressive agents, second-generation
obsessive-compulsive disorder
panic disorder
phobic disorders
stress disorders, post-traumatic
patient education handout

---
http://www.reseau-pic.info/?dest=medicaments/escitalopram.htm&med=SEROPLEX®
2006
France
French
antidepressive agents, second-generation
Selective Serotonin Reuptake Inhibitors
antidepressive agents, second-generation
Selective Serotonin Reuptake Inhibitors
depressive disorder, major
panic disorder
Escitalopram
escitalopram oxalate
escitalopram
escitalopram
escitalopram
patient education handout

---
http://www.reseau-pic.info/?dest=medicaments/sertraline.htm&med=SERTRALINE®
2006
France
French
sertraline
antidepressive agents
Selective Serotonin Reuptake Inhibitors
sertraline
Selective Serotonin Reuptake Inhibitors
antidepressive agents
obsessive-compulsive disorder
depressive disorder, major
patient education handout

---
https://minerva-ebp.be/fr/article/842
2004
false
false
minerva-ebm.be
Belgium
French
child
adolescent
depression
depressive disorder, major
Selective Serotonin Reuptake Inhibitors
sertraline
antidepressive agents
treatment outcome
sertraline
antidepressive agents
Selective Serotonin Reuptake Inhibitors
critical appraisal or critical reading

---
Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.